A recent study published in JAMA compared the effectiveness of two medications, methadone and buprenorphine/naloxone, for treating opioid use disorder, revealing that patients treated with methadone had a lower rate of treatment discontinuation over 24 months.
Despite treating older, sicker patients and performing more non-elective surgeries, osteopathic surgeons achieved comparable 30-day mortality rates to their allopathic counterparts, with no significant differences in readmissions or length of stay.
New study: Maternal COVID-19 exposure in utero not linked to increased risk of neurodevelopmental delays in children through 24 months. Read more in JAMA Network Open.
Research published in BMC Primary Care finds that only 44% of patients with opioid use disorder in primary care settings adhere to their prescribed buprenorphine treatment, with male sex and unexpected positive opioid toxicology results associated with lower adherence.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers are making strides in developing the first successful mRNA vaccine against the highly contagious and difficult-to-treat Clostridioides difficile bacteria, with promising results in mice and nonhuman primates.
Electronic nudges boosted flu vaccination rates by up to 13.9 percentage points in chronic disease patients, with the most effective reminder doubling the control group’s rate.
A recent study explores the impact of the COVID-19 pandemic on cancer detection in the U.S., revealing a significant drop in 2020 with certain subgroups still experiencing lower detection rates by 2021.
Study uncovers the crucial role of protein turnover in influenza A virus replication, identifying potential antiviral targets in the host’s cellular machinery.